BSE Live
Dec 26, 14:49Prev. Close
424.45
Open Price
422.25
Bid Price (Qty.)
418.00 (92)
Offer Price (Qty.)
418.45 (44)
NSE Live
Dec 26, 14:49Prev. Close
422.00
Open Price
420.05
Bid Price (Qty.)
417.80 (3)
Offer Price (Qty.)
418.05 (46)
| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 60.57 | 38.48 | 34.41 | 33.46 | 28.38 | |
| Diluted EPS (Rs.) | 60.57 | 38.48 | 34.41 | 33.46 | 28.38 | |
| Cash EPS (Rs.) | 81.61 | 56.11 | 51.89 | 50.41 | 43.46 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 280.04 | 230.45 | 193.12 | 167.72 | 147.58 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 280.04 | 230.45 | 193.12 | 167.72 | 147.58 | |
| Revenue from Operations/Share (Rs.) | 775.15 | 661.92 | 527.36 | 500.97 | 470.68 | |
| PBDIT/Share (Rs.) | 113.00 | 88.96 | 84.61 | 80.02 | 72.55 | |
| PBIT/Share (Rs.) | 92.08 | 70.91 | 67.62 | 63.89 | 57.46 | |
| PBT/Share (Rs.) | 79.52 | 55.56 | 52.80 | 48.63 | 39.34 | |
| Net Profit/Share (Rs.) | 60.69 | 38.06 | 34.90 | 34.29 | 28.38 | |
| NP After MI And SOA / Share (Rs.) | 60.69 | 38.06 | 34.90 | 34.29 | 28.38 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 14.57 | 13.43 | 16.04 | 15.97 | 15.41 | |
| PBIT Margin (%) | 11.87 | 10.71 | 12.82 | 12.75 | 12.20 | |
| PBT Margin (%) | 10.25 | 8.39 | 10.01 | 9.70 | 8.35 | |
| Net Profit Margin (%) | 7.82 | 5.74 | 6.61 | 6.84 | 6.02 | |
| NP After MI And SOA Margin (%) | 7.82 | 5.74 | 6.61 | 6.84 | 6.02 | |
| Return on Networth/Equity (%) | 21.67 | 16.51 | 18.07 | 20.44 | 19.22 | |
| Return on Capital Employed (%) | 22.54 | 19.34 | 20.77 | 21.87 | 23.14 | |
| Return on Assets (%) | 8.96 | 6.16 | 5.92 | 6.86 | 6.23 | |
| Total Debt/Equity (X) | 0.52 | 0.87 | 1.12 | 1.12 | 1.26 | |
| Asset Turnover Ratio (%) | 114.56 | 107.24 | 89.50 | 100.34 | 103.41 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.45 | 1.33 | 1.19 | 1.16 | 1.13 | |
| Quick Ratio (X) | 0.93 | 0.91 | 0.74 | 0.73 | 0.77 | |
| Inventory Turnover Ratio (X) | 5.55 | 6.33 | 4.47 | 5.70 | 6.39 | |
| Dividend Payout Ratio (NP) (%) | 4.94 | 2.62 | 2.89 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 3.67 | 1.78 | 1.94 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 95.06 | 97.38 | 97.11 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 96.33 | 98.22 | 98.06 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 6.36 | 4.18 | 4.56 | 4.19 | 3.17 | |
| Interest Coverage Ratios (Post Tax) (%) | 6.36 | 4.18 | 4.56 | 4.19 | 3.17 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,508.91 | 1,976.21 | 1,698.85 | 1,815.13 | 1,545.49 | |
| EV/Net Operating Revenue (X) | 0.84 | 1.27 | 1.37 | 1.52 | 1.36 | |
| EV/EBITDA (X) | 5.73 | 9.42 | 8.51 | 9.51 | 8.80 | |
| MarketCap/Net Operating Revenue (X) | 0.65 | 0.97 | 0.96 | 1.15 | 0.97 | |
| Retention Ratios (%) | 95.05 | 97.37 | 97.10 | 0.00 | 0.00 | |
| Price/BV (X) | 1.81 | 2.78 | 2.62 | 3.43 | 3.08 | |
| Price/Net Operating Revenue | 0.65 | 0.97 | 0.96 | 1.15 | 0.97 | |
| Earnings Yield | 0.12 | 0.06 | 0.07 | 0.06 | 0.06 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y